2016
DOI: 10.4103/0019-5545.196711
|View full text |Cite
|
Sign up to set email alerts
|

Use of clozapine alongside chemotherapy in a treatment-resistant bipolar disorder patient with ovarian carcinoma: A case report and brief review

Abstract: Regular monitoring of blood counts ensures the safety of clozapine use; however, certain clinical situations may pose a dilemma for management such as use of clozapine in the presence of myelosuppressive chemotherapy. Further, there is very limited literature to guide such decisions. We report a case of a clozapine-stabilized, treatment-resistant bipolar disorder patient with ovarian carcinoma requiring chemotherapy. The clinical challenges are discussed in light of a brief review of the available reports.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…Some data also show that these drugs can be used to augment chemotherapy and treat the side effects of chemotherapy [ 50 ]. Table 1 [ 51 - 69 ] summarizes the most commonly used antipsychotics in oncology settings.…”
Section: Role Of Antipsychotic Medicationsmentioning
confidence: 99%
“…Some data also show that these drugs can be used to augment chemotherapy and treat the side effects of chemotherapy [ 50 ]. Table 1 [ 51 - 69 ] summarizes the most commonly used antipsychotics in oncology settings.…”
Section: Role Of Antipsychotic Medicationsmentioning
confidence: 99%